The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Intrauterine Devices

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Intrauterine Devices


High impact information on Intrauterine Devices


Chemical compound and disease context of Intrauterine Devices


Biological context of Intrauterine Devices


Anatomical context of Intrauterine Devices


Associations of Intrauterine Devices with chemical compounds


Gene context of Intrauterine Devices


Analytical, diagnostic and therapeutic context of Intrauterine Devices


  1. Tubal infertility and the intrauterine device. Cramer, D.W., Schiff, I., Schoenbaum, S.C., Gibson, M., Belisle, S., Albrecht, B., Stillman, R.J., Berger, M.J., Wilson, E., Stadel, B.V. N. Engl. J. Med. (1985) [Pubmed]
  2. A double-blind trial of ethamsylate in the treatment of primary and intrauterine-device menorrhagia. Harrison, R.F., Cambell, S. Lancet (1976) [Pubmed]
  3. Man-to-woman sexual transmission of the human immunodeficiency virus. Risk factors related to sexual behavior, man's infectiousness, and woman's susceptibility. Italian Study Group on HIV Heterosexual Transmission. Lazzarin, A., Saracco, A., Musicco, M., Nicolosi, A. Arch. Intern. Med. (1991) [Pubmed]
  4. Intrauterine devices and pelvic inflammatory disease: meta-analyses of published studies, 1974-1990. Gareen, I.F., Greenland, S., Morgenstern, H. Epidemiology (Cambridge, Mass.) (2000) [Pubmed]
  5. Review of non-hormonal contraception (condoms, intrauterine devices, nonoxynol-9 and combos) on HIV acquisition. Cates, W. J. Acquir. Immune Defic. Syndr. (2005) [Pubmed]
  6. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. Hubacher, D., Lara-Ricalde, R., Taylor, D.J., Guerra-Infante, F., Guzmán-Rodríguez, R. N. Engl. J. Med. (2001) [Pubmed]
  7. Deaths from spontaneous abortion in the United States. Berman, S.M., MacKay, H.T., Grimes, D.A., Binkin, N.J. JAMA (1985) [Pubmed]
  8. Mortality among young black women using contraceptives. Ory, H.W., Rubin, G.L., Jones, V., Wingo, P., DeStefano, F., Peterson, H., Guidotti, R., Layde, P.M., Levenson, A.G., Michelson, M. JAMA (1984) [Pubmed]
  9. Levonorgestrel-releasing intrauterine devices. Gerber, B., Reimer, T., Krause, A., Friese, K., Müller, H. Lancet (2001) [Pubmed]
  10. Detection of Gardnerella vaginalis in vaginal specimens by direct immunofluorescence. Hansen, W., Vray, B., Miller, K., Crokaert, F., Yourassowsky, E. J. Clin. Microbiol. (1987) [Pubmed]
  11. Intraperitoneal levonorgestrel-releasing intrauterine device following uterine perforation: the role of progestins in adhesion formation. Haimov-Kochman, R., Doviner, V., Amsalem, H., Prus, D., Adoni, A., Lavy, Y. Hum. Reprod. (2003) [Pubmed]
  12. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Sivin, I. Obstetrics and gynecology. (1991) [Pubmed]
  13. The effect of low-dose 3-keto-desogestrel added to a copper-releasing intrauterine contraceptive device on menstrual blood loss: a double-blind, dose-finding, placebo-controlled study. Janssen, C.A., Scholten, P.C., Heintz, A.P. Am. J. Obstet. Gynecol. (2000) [Pubmed]
  14. Tranexamic acid, intrauterine contraceptive devices and fatal cerebral arterial thrombosis. Case report. Agnelli, G., Gresele, P., De Cunto, M., Gallai, V., Nenci, G.G. British journal of obstetrics and gynaecology. (1982) [Pubmed]
  15. The secretion of human chorionic gonadotropin-like substance in women employing contraceptive measures. Huang, S.C., Chen, H.C., Chen, R.J., Hsieh, C.Y., Wei, P.Y., Ouyang, P.C. J. Clin. Endocrinol. Metab. (1984) [Pubmed]
  16. The effect of the IUD and prostaglandin F2 alpha on luteolysis in the pregnant hamster. Hubbard, C.J., Bo, W.J., Krueger, W.A. Biol. Reprod. (1978) [Pubmed]
  17. Progesterone and estradiol patterns in women using an intrauterine contraceptive device. Brenner, P.F., Mishell, D.R. Obstetrics and gynecology. (1975) [Pubmed]
  18. Norplant((R)) implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning. Díaz, S., Reyes, M.V., Zepeda, A., González, G.B., López, J.M., Campino, C., Croxatto, H.B. Hum. Reprod. (1999) [Pubmed]
  19. The menstrual cycle in women using an intrauterine device. Faundes, A., Segal, S.J., Adejuwon, C.A., Brache, V., Leon, P., Alvarez-Sanchez, F. Fertil. Steril. (1980) [Pubmed]
  20. Prostaglandin E and F concentrations in human endometrium after insertion of intrauterine contraceptive device. Hillier, K., Kasonde, J.M. Lancet (1976) [Pubmed]
  21. Hippocampal changes in developing postnatal mice following intrauterine exposure to domoic acid. Dakshinamurti, K., Sharma, S.K., Sundaram, M., Watanabe, T. J. Neurosci. (1993) [Pubmed]
  22. Alterations in progesterone receptors in the rat uterus bearing an intra-uterine device during the oestrous cycle and early pregnancy. Myatt, L., Elder, M.G., Lim, L. J. Endocrinol. (1980) [Pubmed]
  23. Bacterial flora of the cervix in women using different methods of contraception. Haukkamaa, M., Stranden, P., Jousimies-Somer, H., Siitonen, A. Am. J. Obstet. Gynecol. (1986) [Pubmed]
  24. Expression of alpha4beta1 and alphavbeta3 integrins in the endometrium of women using the T200 copper intrauterine device. Savaris, R., Zettler, C.G., Ferrari, A.N. Fertil. Steril. (2000) [Pubmed]
  25. Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Walsh, T., Grimes, D., Frezieres, R., Nelson, A., Bernstein, L., Coulson, A., Bernstein, G. Lancet (1998) [Pubmed]
  26. Anti-prostglandin therapy in prevention of side-effects of intrauterine contraceptive devices. Ylikorkala, O., Kauppila, A., Siljander, M. Lancet (1978) [Pubmed]
  27. Calcium carbonate and intrauterine devices. Davis, R.H. Lancet (1977) [Pubmed]
  28. Intrauterine progestin induces continuous insulin-like growth factor-binding protein-1 production in the human endometrium. Pekonen, F., Nyman, T., Lähteenmäki, P., Haukkamaa, M., Rutanen, E.M. J. Clin. Endocrinol. Metab. (1992) [Pubmed]
  29. Cells adherent to IUDs produce tumor necrosis factor alpha. Trebichavský, I., Nyklícek, O. Contraception. (1993) [Pubmed]
  30. Effect of intrauterine contraceptive devices on cytokine messenger ribonucleic acid expression in the human endometrium. Ammälä, M., Nyman, T., Strengell, L., Rutanen, E.M. Fertil. Steril. (1995) [Pubmed]
  31. Ovarian function during use of a levonorgestrel-releasing IUD. Barbosa, I., Bakos, O., Olsson, S.E., Odlind, V., Johansson, E.D. Contraception. (1990) [Pubmed]
  32. Impairment of immunity during pregnancy and antiviral effect of amniotic fluid. Pacsa, A.S. Lancet (1977) [Pubmed]
  33. Issues in fertility control for mentally retarded female adolescents: I. Sexual activity, sexual abuse, and contraception. Chamberlain, A., Rauh, J., Passer, A., McGrath, M., Burket, R. Pediatrics (1984) [Pubmed]
  34. Current use of an intrauterine device and risk of tubal pregnancy. Rossing, M.A., Daling, J.R., Voigt, L.F., Stergachis, A.S., Weiss, N.S. Epidemiology (Cambridge, Mass.) (1993) [Pubmed]
  35. IUD-associated hospitalization in less developed countries. Chi, I.C., Laufe, L., Rogers, S. American journal of public health. (1984) [Pubmed]
  36. Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating women. Ratchanon, S., Taneepanichskul, S. Obstetrics and gynecology. (2000) [Pubmed]
  37. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy. Bourdrez, P., Bongers, M.Y., Mol, B.W. Fertil. Steril. (2004) [Pubmed]
WikiGenes - Universities